JP2022523663A5 - - Google Patents
Info
- Publication number
- JP2022523663A5 JP2022523663A5 JP2021542408A JP2021542408A JP2022523663A5 JP 2022523663 A5 JP2022523663 A5 JP 2022523663A5 JP 2021542408 A JP2021542408 A JP 2021542408A JP 2021542408 A JP2021542408 A JP 2021542408A JP 2022523663 A5 JP2022523663 A5 JP 2022523663A5
- Authority
- JP
- Japan
- Prior art keywords
- liver
- subject
- administered
- pharmaceutical composition
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962796806P | 2019-01-25 | 2019-01-25 | |
| US62/796,806 | 2019-01-25 | ||
| PCT/US2020/014934 WO2020154585A1 (en) | 2019-01-25 | 2020-01-24 | Methods for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022523663A JP2022523663A (ja) | 2022-04-26 |
| JP2022523663A5 true JP2022523663A5 (https=) | 2024-08-16 |
Family
ID=69740558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542408A Ceased JP2022523663A (ja) | 2019-01-25 | 2020-01-24 | 放射線処置および／または放射線模倣剤処置を伴う、肝損傷を緩和し、肝臓の肥厚、再生、および細胞の生着を促進するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200237871A1 (https=) |
| EP (1) | EP3914272B1 (https=) |
| JP (1) | JP2022523663A (https=) |
| KR (1) | KR20210141460A (https=) |
| CN (1) | CN113766926A (https=) |
| AU (1) | AU2020211412A1 (https=) |
| CA (1) | CA3127455A1 (https=) |
| ES (1) | ES2978584T3 (https=) |
| IL (1) | IL285094A (https=) |
| MA (1) | MA54820A (https=) |
| MX (1) | MX2021008943A (https=) |
| WO (1) | WO2020154585A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018306329B8 (en) | 2017-07-26 | 2025-02-20 | Janssen Pharmaceutica Nv | Methods of protecting vascular integrity induced by targeted radiation therapy |
| CN113018424B (zh) * | 2019-12-25 | 2023-05-02 | 中国科学院分子细胞科学卓越创新中心 | Cst1在预防和/或治疗肝脏免疫失调疾病中的应用 |
| WO2023056444A1 (en) * | 2021-10-01 | 2023-04-06 | Janssen Pharmaceutica N.V. | Methods of increasing progenitor cell production |
| CN119654158A (zh) * | 2022-05-20 | 2025-03-18 | 詹森药业有限公司 | 用于减轻与暴露于辐射和/或辐射或拟辐射治疗相关的肺损伤的方法 |
| KR20250072705A (ko) * | 2022-08-24 | 2025-05-26 | 몬테피오레 메디컬 센터 | 혈소판 감소증 및 급성 방사선 증후군을 위한 flt3 리간드 이중 작용성 분자 |
| WO2024095178A1 (en) * | 2022-11-01 | 2024-05-10 | Janssen Pharmaceutica Nv | Thrombopoietin mimetic for use in the treatment of acute liver failure |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU680422B2 (en) | 1992-06-11 | 1997-07-31 | Alkermes Controlled Therapeutics, Inc. | Erythropoietin drug delivery system |
| US5354934A (en) | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
| US5869451A (en) | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| US7091311B2 (en) | 1996-06-07 | 2006-08-15 | Smithkline Beecham Corporation | Peptides and compounds that bind to a receptor |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| US20020147158A1 (en) * | 2001-02-27 | 2002-10-10 | University Of Southern California | Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease |
| SG131110A1 (en) | 2003-08-28 | 2007-04-26 | Ortho Mcneil Pharm Inc | Peptides and compounds that bind to thrombopoietin receptors |
| US7723295B2 (en) | 2003-08-28 | 2010-05-25 | Ortho-Mcneil Pharmaceutical, Inc. | Peptides and compounds that bind to a receptor |
| US20060210542A1 (en) | 2004-08-16 | 2006-09-21 | Yurkow Edward J | Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia |
| US7615533B2 (en) | 2004-08-16 | 2009-11-10 | Janssen Pharmaceutica N.V. | TPO peptide compounds for treatment of anemia |
| DK1984014T3 (da) | 2006-02-14 | 2014-09-15 | Janssen Pharmaceutica Nv | Anvendelse af tpo-peptidforbindelser og farmaceutiske sammensætninger ved behandlingen af anæmi |
| CA2670345A1 (en) * | 2006-12-01 | 2008-06-12 | Stategics, Inc. | Thrombopoietin mimetics |
| ES2729622T3 (es) | 2008-06-03 | 2019-11-05 | Janssen Pharmaceutica Nv | Péptido mimético de TPO para prevenir el desorden hematológico asociado al tratamiento contra el cáncer |
| JP2012518408A (ja) * | 2009-02-24 | 2012-08-16 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 治療用ｔｐｏ／ｅｐｏ模倣ペプチドを含む抗体 |
| SG11201705809QA (en) * | 2015-01-27 | 2017-08-30 | Scipharm Sàrl | Composition for the treatment of hepatic veno-occlusive disease |
| AU2018306329B8 (en) * | 2017-07-26 | 2025-02-20 | Janssen Pharmaceutica Nv | Methods of protecting vascular integrity induced by targeted radiation therapy |
| WO2020154637A1 (en) * | 2019-01-25 | 2020-07-30 | Janssen Pharmaceutica Nv | Methods of enhancing protection against organ and vascular injury, hematopoietic recovery and survival in response to total body radiation/chemical exposure |
-
2020
- 2020-01-24 MX MX2021008943A patent/MX2021008943A/es unknown
- 2020-01-24 AU AU2020211412A patent/AU2020211412A1/en active Pending
- 2020-01-24 WO PCT/US2020/014934 patent/WO2020154585A1/en not_active Ceased
- 2020-01-24 JP JP2021542408A patent/JP2022523663A/ja not_active Ceased
- 2020-01-24 US US16/752,168 patent/US20200237871A1/en not_active Abandoned
- 2020-01-24 CA CA3127455A patent/CA3127455A1/en active Pending
- 2020-01-24 MA MA054820A patent/MA54820A/fr unknown
- 2020-01-24 EP EP20708757.8A patent/EP3914272B1/en active Active
- 2020-01-24 KR KR1020217026846A patent/KR20210141460A/ko not_active Ceased
- 2020-01-24 CN CN202080023484.5A patent/CN113766926A/zh active Pending
- 2020-01-24 ES ES20708757T patent/ES2978584T3/es active Active
-
2021
- 2021-07-23 IL IL285094A patent/IL285094A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523663A5 (https=) | ||
| EP3914272B1 (en) | Thrombopoietin mimetics for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments | |
| JP6613312B2 (ja) | 膵臓癌を処置するためのペプチドをベースとする方法 | |
| Popovtzer et al. | Actively targeted gold nanoparticles as novel radiosensitizer agents: an in vivo head and neck cancer model | |
| KR102688415B1 (ko) | 표적화된 방사선 치료요법에 의해 유도된 혈관 무결성을 보호하는 조성물 | |
| JP7664163B2 (ja) | 全身照射／化学曝露に対する応答において臓器および血管損傷、造血回復ならびに生存に対する保護を増強する方法 | |
| Hansen et al. | Liposome accumulation in irradiated tumors display important tumor and dose dependent differences | |
| US20250269075A1 (en) | Method of Treating Cancer by Intratumoral Deposition of Radioactive Microparticles | |
| US9345704B2 (en) | Materials and methods for suppressing and/or treating neurofibroma and related tumors | |
| HK40064882B (en) | Thrombopoietin mimetics for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments | |
| HK40064882A (en) | Thrombopoietin mimetics for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments | |
| Comito et al. | Systemic and liver-directed therapies in metastatic uveal melanoma: State-of-the-art and novel perspectives | |
| US20250312417A1 (en) | Methods for Mitigating Lung Injury in Conjunction with Exposure to Radiation and/or Radiation or Radiomimetic Treatments | |
| CN111511386A (zh) | α-1-微球蛋白用于保护骨髓细胞的用途 | |
| KR20220145861A (ko) | 암 및 종양을 치료하기 위한 조성물 및 방법 | |
| Miyauchi | The Role of Neuropilin 1 in Glioma Associated Microglia and Macrophages | |
| Lung | 19 The Lung, Pleura, and Thymus |